197 related articles for article (PubMed ID: 31661150)
1. Immunotherapy Advances: 2019.
Saleh N
Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661150
[TBL] [Abstract][Full Text] [Related]
2. Emerging new anticancer therapies in 2013.
Gomez-Roca C; Delord JP
Curr Opin Oncol; 2014 May; 26(3):357-62. PubMed ID: 24709976
[TBL] [Abstract][Full Text] [Related]
3. Target therapy for metastatic breast cancer.
Rachdi H; Mokrani A; Batti R; Ayadi M; Chraiet N; Mezlini A
Tunis Med; 2018; 96(8-9):465-471. PubMed ID: 30430522
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic antibodies: Discovery, design and deployment.
Ramsland PA; Hutchinson AT; Carter PJ
Mol Immunol; 2015 Oct; 67(2 Pt A):1-3. PubMed ID: 25990602
[TBL] [Abstract][Full Text] [Related]
7. [TGF-β-targeted immunotherapy aiming for new and efficient treatments of cancer].
Foughali R; Marie JC
Med Sci (Paris); 2020 Jan; 36(1):77-79. PubMed ID: 32014103
[No Abstract] [Full Text] [Related]
8. State of melanoma: an historic overview of a field in transition.
Gorantla VC; Kirkwood JM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):415-35. PubMed ID: 24880939
[TBL] [Abstract][Full Text] [Related]
9. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy and targeted therapy, a promising combination to fight cancer].
Andrieu N; Bendriss-Vermare N
Med Sci (Paris); 2018 Oct; 34(10):872-875. PubMed ID: 30451657
[No Abstract] [Full Text] [Related]
11. [Description of adverse events in publications of clinical trials: much room for improvement.].
Di Maio M; Antonuzzo A; Bossi P
Recenti Prog Med; 2019; 110(7):323-324. PubMed ID: 31379365
[TBL] [Abstract][Full Text] [Related]
12. Successes and limitations of targeted therapies in renal cell carcinoma.
Pracht M; Berthold D
Prog Tumor Res; 2014; 41():98-112. PubMed ID: 24727990
[TBL] [Abstract][Full Text] [Related]
13. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
14. Potential of CD73 as a target for cancer immunotherapy.
Jadidi-Niaragh F
Immunotherapy; 2019 Nov; 11(16):1353-1355. PubMed ID: 31578906
[No Abstract] [Full Text] [Related]
15. Advances in Cancer Therapy: Immunotherapies.
Marmé D
Oncol Res Treat; 2016; 39(6):324-5. PubMed ID: 27260772
[No Abstract] [Full Text] [Related]
16. The rapidly evolving therapies for advanced melanoma--Towards immunotherapy, molecular targeted therapy, and beyond.
Zhu Z; Liu W; Gotlieb V
Crit Rev Oncol Hematol; 2016 Mar; 99():91-9. PubMed ID: 26708040
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in malignant melanoma.
Atkinson V
Intern Med J; 2017 Oct; 47(10):1114-1121. PubMed ID: 28994264
[TBL] [Abstract][Full Text] [Related]
18. Cancer therapy: an evolved approach.
Willyard C
Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
[No Abstract] [Full Text] [Related]
19. [Unleashing NK cell signaling to improve cancer immunotherapy].
Bernard PL; Laletin V; Pastor S; Nunès JA; Guittard G
Med Sci (Paris); 2020 Oct; 36 Hors série n° 1():50-55. PubMed ID: 33052095
[No Abstract] [Full Text] [Related]
20. [Targeted therapy in glioblastoma: update and perspectives].
Idbaih A; Duran-Peña A; Alentorn A
Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]